Vor Biopharma Inc (VOR)

03:11 AM

Vor Biopharma (VOR) Is Up 45.6% After Telitacicept Phase 3 Win And JPMorgan Nod Has The Bull Case Changed? - Yahoo Finance

03:11 AM

Dec 10, 2025

Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price (VOR) - Seeking Alpha

Dec 10, 2025

Dec 10, 2025

Vor Biopharma (VOR): Valuation Check After Positive Telitacicept Phase 3 Data and Upbeat JPMorgan Coverage - Yahoo Finance

Dec 10, 2025

Dec 09, 2025

Vor Biopharma’s Recent Developments: Stock Impact Analyzed - StocksToTrade

Dec 09, 2025

Dec 09, 2025

Biotech stock soars 40% on JPMorgan’s bold call - Rolling Out

Dec 09, 2025

Dec 09, 2025

Vor Biopharma (VOR) Surges on J.P. Morgan's Bullish Outlook - GuruFocus

Dec 09, 2025

Dec 09, 2025

Vor Bio stock gains bullish view at J.P. Morgan (VOR:NASDAQ) - Seeking Alpha

Dec 09, 2025

Dec 09, 2025

Vor Biopharma (VOR) Stock Surges as JPMorgan Just Made a Massive Call on This Biotech - parameter.io

Dec 09, 2025

Dec 09, 2025

Vor Biopharma’s Telitacicept: A Promising Buy Amidst Valuation Disconnect and Strategic Focus on Unmet Needs - TipRanks

Dec 09, 2025

Dec 09, 2025

Vor Biopharma Stock Surge: Strategic Move or Short-Lived Spike? - timothysykes.com

Dec 09, 2025

Dec 09, 2025

Vor Biopharma reprices stock options for employees and executives By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

VOR shares rally over 40% in pre-market trade after JPMorgan initiates bullish coverage - MSN

Dec 09, 2025

Dec 09, 2025

Vor Biopharma (NASDAQ:VOR) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat

Dec 09, 2025

Dec 09, 2025

Vor Biopharma Approves Stock Option Repricing Plan - TipRanks

Dec 09, 2025

Dec 09, 2025

Vor Biopharma reprices stock options for employees and executives - Investing.com

Dec 09, 2025

Dec 09, 2025

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage - Stocktwits

Dec 09, 2025

Dec 09, 2025

JPMorgan Initiates Vor Biopharma at Overweight With $43 Price Target - marketscreener.com

Dec 09, 2025

Dec 09, 2025

Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews

Dec 09, 2025

Dec 09, 2025

JP Morgan Initiates Coverage on Vor Biopharma (VOR) with Overwei - GuruFocus

Dec 09, 2025

Dec 09, 2025

Vor Bio jumps as J.P.Morgan initiates with 'overweight' rating - TradingView

Dec 09, 2025

Dec 09, 2025

Vor Bio initiated with an Overweight at JPMorgan - TipRanks

Dec 09, 2025

Dec 09, 2025

JPMorgan initiates Vor Biopharma stock with Overweight rating, $43 target By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

JPMorgan initiates Vor Biopharma stock with Overweight rating on telitacicept potential - Investing.com

Dec 09, 2025

Dec 09, 2025

JPMorgan initiates Vor Biopharma stock with Overweight rating, $43 target - Investing.com

Dec 09, 2025

Dec 09, 2025

Vor Biopharma (NASDAQ:VOR) Expands Innovation In Hematologic Therapy - Kalkine Media

Dec 09, 2025

Dec 09, 2025

JPMorgan Starts Vor Biopharma, Inc. (VOR) at Overweight - StreetInsider

Dec 09, 2025

Dec 07, 2025

Profit Review: Will Vor Biopharma Inc stock maintain momentum in 2025 - moha.gov.vn

Dec 07, 2025

Dec 06, 2025

Vor Biopharma slumps 26%, prices $100M equity at $10 per share - MSN

Dec 06, 2025

Dec 03, 2025

Will Vor Biopharma Inc. stock maintain momentum in 2025Gold Moves & Capital Efficiency Focused Strategies - Newser

Dec 03, 2025

Dec 03, 2025

What drives Vor Biopharma Inc stock priceEarnings Surprise Analysis & Superior Capital Trading Plans - earlytimes.in

Dec 03, 2025

Dec 02, 2025

Is There An Opportunity With Vor Biopharma Inc.'s (NASDAQ:VOR) 49% Undervaluation? - Yahoo Finance

Dec 02, 2025

Dec 02, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Dec 02, 2025

Dec 01, 2025

Form 424B3 Vor Biopharma Inc. - StreetInsider

Dec 01, 2025

Nov 28, 2025

Wedbush Predicts Vor Biopharma's Q4 Earnings (NASDAQ:VOR) - MarketBeat

Nov 28, 2025

Nov 26, 2025

How Vor Biopharma Inc. stock benefits from global expansionLayoff News & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ

Nov 26, 2025

Nov 26, 2025

Wedbush Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat

Nov 26, 2025

Nov 25, 2025

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 25, 2025

Nov 25, 2025

Wedbush Initiates Coverage on Vor Biopharma (VOR) with Neutral R - GuruFocus

Nov 25, 2025

Nov 25, 2025

Wedbush Boosts Price Target on Vor Biopharma to $9 From $0.40, Keeps Neutral Rating - marketscreener.com

Nov 25, 2025

Nov 25, 2025

Wedbush Assumes Vor Biopharma, Inc. (VOR) at Neutral - StreetInsider

Nov 25, 2025

Nov 21, 2025

Vor Biopharma Inc. (VOR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Will Vor Biopharma Inc. stock attract more institutional investorsWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com

Nov 21, 2025

Nov 21, 2025

Why retail investors favor Vor Biopharma Inc. stock2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com

Nov 21, 2025

Nov 20, 2025

What technical signals suggest for Vor Biopharma Inc. stockQuarterly Profit Summary & Verified Momentum Stock Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Combining price and volume data for Vor Biopharma Inc.2025 Big Picture & Technical Confirmation Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

How currency fluctuations impact Vor Biopharma Inc. stockFed Meeting & Real-Time Buy Signal Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Can a trend reversal in Vor Biopharma Inc. lead to recoveryWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Using data models to predict Vor Biopharma Inc. stock movementJuly 2025 Pullbacks & Low Drawdown Momentum Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Using Python tools to backtest Vor Biopharma Inc. strategiesJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com

Nov 19, 2025